C1q Nephropathy: The Unique Underrecognized Pathological Entity

Area of Science:

• Nephrology
• Immunopathology

Background:

• C1q nephropathy is a rare glomerular disease defined by mesangial C1q deposition.
• Histological features are heterogeneous, including minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), and proliferative glomerulonephritis.
• Clinical presentations vary widely, from asymptomatic findings to nephritic or nephrotic syndromes.

Purpose of the Study:

• To review the current understanding of C1q nephropathy.
• To discuss its pathogenesis, histopathology, clinical features, treatment, and outcomes.

Main Methods:

• Review of existing literature on C1q nephropathy.
• Analysis of histopathological findings (immunofluorescence, light microscopy).
• Correlation of clinical presentation with histological subtypes and outcomes.

Main Results:

• C1q nephropathy presents heterogeneously across light microscopy and clinical scenarios.
• Hypertension and renal insufficiency are common at diagnosis.
• Nephrotic syndrome and FSGS correlate with adverse outcomes, while MCD suggests a better prognosis.

Conclusions:

• C1q nephropathy requires further research to be recognized as a distinct clinical entity.
• Treatment is guided by light microscopic findings, with corticosteroids as the primary therapy.
• Prognosis varies significantly based on histological subtype and clinical presentation.